top of page
My Yale photo_v1.jpg

Assistant Professor

Chih Hung Lo, Ph.D.

Chih Hung obtained his Ph.D. from University of Minnesota where he investigated the molecular mechanisms of inflammation (TNF receptor signaling) and neurodegeneration (tau aggregation) and launched several drug discovery campaigns. In his postdoctoral trainings, Chih Hung delved into the neurobiology of aging by utilizing mouse genetics to study Alzheimer’s disease (AD) at Brigham and Women’s Hospital/Harvard Medical School and performed neuropathological studies on multiple sclerosis (MS) at Yale School of Medicine. Prior to joining Syracuse University, Chih Hung was a Dean’s Postdoctoral Fellow and an Early-Career Investigator in LKC School of Medicine at NTU Singapore, where he studied the role of autophagy and lysosomal dysfunction driven by TNF receptor signaling and tau aggregation in AD. Chih Hung is currently an Assistant Professor in the Department of Biology, Interdisciplinary Neuroscience Program, and BioInspired Institute at Syracuse University.

Chih Hung’s research interests focus on dissecting the interplay between inflammation and autolysosomal dysfunction that drives neuroinflammation and neurodegeneration in AD and MS, as well as obesity-induced body-brain interaction. The translational aspect of his research combines the use of interdisciplinary approaches to elucidate the structure-function relationships of TNF receptors and conformational ensembles of intrinsically disordered proteins. He applied the structural and conformational understanding of these proteins in biosensor engineering and high-throughput screening for drug discovery targeting inflammation as well as metabolic and neurodegenerative disorders. He also has a keen interest in nanomedicine engineering for brain targeting. Chih Hung holds 3 patents and has published over 35 articles in reputable journals including Alzheimer’s & Dementia, Translational Neurodegeneration, Journal of Neuroinflammation, Nature Communications, PNAS, ACS Nano, and Science Signaling.

Education and Experiences
Assistant Professor (Biology & Interdisciplinary Neuroscience Program), Syracuse University, USA (2025-Present)
Dean's Postdoctoral Fellow (Neuroscience), Nanyang Technological University (NTU), LKC Medicine, Singapore (2021-2024)
Postdoctoral Associate (Neurology), Yale University, School of Medicine, USA (2020-2021)
Postdoctoral Associate (Neurology), Brigham and Women's Hospital/Harvard Medical School, USA (2019-2020)
Ph.D. (Biomedical Engineering), Minor in Management of Technology, University of Minnesota (UMN), USA (2014-2019) 
B.Eng. (Biomedical Engineering), National University of Singapore (NUS), Singapore (2010-2014)

B.B.A. (Operation Management), National University of Singapore (NUS), Singapore (2010-2014)

Honors and Awards
2024                BBA Rising Stars in Biochemistry & Biophysics (contribution to TNF receptor signaling mechanisms)
2024 (Mar)      Early-Career Scientist Research Excellence Award, NTU, Singapore
2023 (Nov)      Trainee Professional Development Award, Society for Neuroscience (SfN), USA

2023 (Mar)      1 of the 10 Young Scientists selected by the National Research Foundation as Singapore representatives,
                        72nd Lindau Nobel Laureate Meeting (Physiology or Medicine), Germany

2023 (Mar)      Travel Award, Keystone Symposia on Autophagy & Neurodegeneration, USA
2022-2023       Mistletoe Research Fellowship (Unfettered Research Grant), Momental Foundation, USA
2022 (Sep)      Silver Award - Tan Kah Kee Young Inventors National Competition (Open Category)
2022 (May)      Best Poster Award, 1st Singapore Structural Biology Symposium (SSBS), Singapore
2021–2024      Dean’s Postdoctoral Fellowship (Independent Research Grant), LKC Medicine, NTU, Singapore  
2020–2021      NUS Development Grant (Named Young NUS Fellow)
2020 (Jun)       Best Dissertation Award (Ph.D.), Honorable Mention, University-Wide Competition, University of Minnesota, USA
2020 (May)      BME Department Best Dissertation Award (Ph.D.), University of Minnesota, USA
2020 (Apr)       Featured for Mentor-Graduate Student Spotlight, Journal of Life Sciences
2019  (Oct)      Trainee Professional Development Award, Society for Neuroscience (SfN), USA
2018–2019      Doctoral Dissertation Fellowship, University of Minnesota, USA
2018 (Nov)      Travel Grant, Council of Graduate Students, University of Minnesota, USA
2018 (Aug)      Travel Grant for National Meeting, Division of Medicinal Chemistry, American Chemical Society (ACS), USA
2018 (Feb)      Travel Award for Annual Meeting, Biophysical Society (BPS), USA

2017 (Apr)       Travel Award for Annual Meeting, American Society for Biochemistry and Molecular Biology (ASBMB), USA 
2017 (Jan)       Travel Fellowship, Invitation to the Global Young Scientists Summit, Singapore
2015 (Apr)       Culture Corps Award, ISSS, University of Minnesota, USA
2014 (Apr)       Best Presentation Award (Senior Thesis), 1st Prize, Biomedical Engineering Showcase, NUS, Singapore
2013 (Jan)       Award for Study Abroad Exchange Scholarship to University of California, San Diego (UCSD), NUS, Singapore
2012 (May)      Best Poster Award, Biomedical Engineering Society (Singapore) 6th Scientific Meeting, Singapore


Link to Publication List for Chih Hung Lo
 
Patents
1.  Lo CH, Zeng J, Perez-Aguilar JM, Baizabal-Aguirre VM. Peptide-based therapeutics with anti-inflammatory properties.
Singapore Provisional Patent Application No. 10202400831U.
2.  Sachs JN & Lo CH. Methods to identify modulator of tau protein structure. US Patent No. 11/726,081.

3.  Wood DK, Sachs JN, Vunnam N, Lo CH. Non-fibrillar hemoglobin oligomers and methods to identify modulators of hemoglobin S polymerization. US Patent Application No. 17/953,981.

Grants
Dean’s Postdoctoral Fellowship, LKC School of Medicine,  Nanyang Technological University, Singapore (PI: Lo)           Project Title: Role of aberrant TNFR1 signaling in Alzheimer’s disease

Timeline: 2021 – 2024 (Completed)
Mistletoe Research Fellowship, Momental Foundation, USA (PI: Lo)      
Project Title: Unfettered research grant supporting the development of lysosome-acidifying nanoparticles targeting metabolic and neurodegenerative diseases
Timeline: 2022 – 2023 (Completed)

bottom of page